MOLECULAR AND CELLULAR EFFECTS OF ONCOGENE COOPERATION IN A GENETICALLY ACCURATE AML MOUSE MODEL
Reckzeh K. et al, (2013), ANNALS OF HEMATOLOGY, 92, S1 - S2
A study to evaluate the cause of bone demineralization in gynecological cancer survivors.
Stavraka C. et al, (2013), Oncologist, 18, 423 - 429
CONTINUOUS LOW-FLOW ASCITES-DRAINAGE AND SEQUENTIAL NON-INVASIVE TUMOR-CELL SAMPLING THROUGH THE URINARY BLADDER VIA THE ALFA-PUMP CLOSED SYSTEM IN PLATINUM-RESISTANT-OVARIAN-CANCER (PROC)
Fotopoulou C. et al, (2013), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23
Early stage mucinous ovarian carcinomas: 10 years of experience in a tertiary centre
Chatterjee J. et al, (2013), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 120, 282 - 283
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma
Collins GP. et al, (2013), British Journal of Haematology
Management of ascites via the alfa-pump closed system in platinum-resistant-ovarian-cancer (PROC): A model of sequential non-invasive tumor-cell sampling through the urinary bladder
Fotopoulou C. et al, (2013), CLINICAL CANCER RESEARCH, 19
Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary team.
Cubitt JJ. et al, (2013), J Skin Cancer, 2013
New treatment approaches in melanoma: current research and clinical prospects.
Rughani MG. et al, (2013), Ther Adv Med Oncol, 5, 73 - 80
OUTCOMES IN MUCINOUS OVARIAN CARCINOMAS: 10 YEARS OF EXPERIENCE IN A TERTIARY CENTRE
Hopkins TG. et al, (2013), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23
THE IMPACT OF OVARIAN CANCER TREATMENT ON WOMEN'S SEXUAL WELLBEING
Hopkins TG. et al, (2013), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.
Eyre T. et al, (2012), Blood, 120, 4441 - 4443
Phase 1 (Ph1) Clinical and Pharmacodynamic (PD) Study of a Pure MEK Inhibitor (MEKi), RO4987655, in RAS-BRAF Mutant Patient Populations with Advanced or Metastatic Solid Tumors
Bahleda R. et al, (2012), EUROPEAN JOURNAL OF CANCER, 48, 75 - 75
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).
Lebbe C. et al, (2012), Eur J Cancer, 48, 3205 - 3214
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: A retrospective, longitudinal survey (MELODY study)
Lebbe C. et al, (2012), European Journal of Cancer, 48, 3205 - 3214
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.
Roy A. et al, (2012), Proc Natl Acad Sci U S A, 109, 17579 - 17584
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.
Su Z. et al, (2012), Nat Genet, 44, 1131 - 1136
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012.
Garbe C. et al, (2012), Eur J Cancer, 48, 2375 - 2390
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012
Garbe C. et al, (2012), European Journal of Cancer, 48, 2375 - 2390
High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
Leslie T. et al, (2012), Br J Radiol, 85, 1363 - 1370
Sentinel node status predicts survival in thick melanomas: The Oxford perspective
Rughani MG. et al, (2012), European Journal of Surgical Oncology, 38, 936 - 942